1239840-95-9

Upstream product

• 618-51-9 3-Iodobenzoic acid 
• 137-07-5 2-amino-benzenethiol 
• 339025-86-4 2-(3-iodophenyl)-1,3-benzothiazole 

Downstream Products

• 1380347-45-4 n-butyl 4-((2-[(2R)-2-((1E,3S)-4-[3-(1,3-benzothiazol-2-yl)phenyl]-3-hydroxy-1-buten-1-yl)-5-oxo-1-pyrrolidinyl]ethyl)thio)butanoate 
• 494224-12-3 4-([2-((2R)-2-((1E,3S)-4-[3-(1,3-benzothiazol-2-yl)phenyl]-3-hydroxybut-1-enyl)-5-oxopyrrolidin-1-yl)ethyl]sulfanyl)butanoic acid 
• 1380347-37-4 N-methoxy-N-methyl-2-[3-(1,3-benzothiazol-2-yl)phenyl]acetamide 
• 1380347-13-6 dimethyl (3-[3-(1,3-benzothiazol-2-yl)phenyl]-2-oxopropyl)phosphonate 
• 494224-15-6 2-([2-((2R)-2-((1E,3S)-4-[3-(1,3-benzothiazol-2-yl)phenyl]-3-hydroxybut-1-enyl)-5-oxopyrrolidin-1-yl)ethyl]sulfanyl)-1,3-thiazole-4-carboxylic acid 
• 1380347-48-7 n-butyl 2-((2-[(2R)-2-((1E,3S)-4-[3-(1,3-benzothiazol-2-yl)phenyl]-3-hydroxy-1-buten-1-yl)-5-oxo-1-pyrrolidinyl]ethyl)thio)-1,3-thiazole-4-carboxylate 

Relevant academic research and scientific papers

Synthesis and evaluation of γ-lactam analogs of PGE2 as EP4 and EP2/EP4 agonists

To identify topically effective EP4 agonists and EP2/EP4 dual agonists with excellent subtype selectivity, further optimization of the 16-phenyl ω-chain moiety of the γ-lactam 5-thia prostaglandin E analog and the 2-mercaptothiazole-4-carboxylic acid anal